Brief: Glenmark Pharma Says Unit Launches Olanzapine For Injection, 10 Mg/Vial, Single-Dose Vial
06/07/2026 08:09
BRIEF-Glenmark Pharma Says Unit Launches Olanzapine For Injection, 10 Mg/Vial, Single-Dose Vial July 6 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS:
GLENMARK PHARMA - UNIT LAUNCHES OLANZAPINE FOR INJECTION, 10 MG/VIAL, SINGLE-DOSE VIAL
Source text: ID:nNSEby57T0
Further company coverage: GLEN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter